Global Gut Health Probiotic Supplements Market - 2024-2031

Global Gut Health Probiotic Supplements Market - 2024-2031


Global Gut Health Probiotic Supplements Market reached US$ 4.8 billion in 2023 and is expected to reach US$ 10.4 billion by 2031, growing with a CAGR of 11.1% during the forecast period 2024-2031.

Rising health consciousness, ageing populations, and lifestyle changes impact digestive health and lead to various disorders. The global gut health probiotic supplements market has been expanding steadily, driven by increasing consumer awareness of the digestive health benefits associated with probiotics. With increasing awareness about the importance of maintaining a healthy digestive system for overall well-being, consumer focus on gut health drives market growth.

Consumers prefer probiotics to deal with respective and specific health conditions. In 2022, CRN reported that there had been a rise in the usage of speciality supplements. Over half of the supplement, consumers (52%) incorporate specialty supplements into their system, with the most commonly used types including omega-3s, probiotics, melatonin and fiber.

North America dominates the market with the high demand for digestive health care products. According to NIH, around 60 to 70 million people in the U.S. live with a digestive disease. The Council for Responsible Nutrition surveyed in August 2022 and stated that among 3,133 U.S. adults aged 18 and older, including 2,342 adults they indicated they use dietary supplements occasionally, regularly, or seasonally.

Dynamics

Growing Health Consciousness Among Consumers

With the increasing prevalence of digestive and gut health problems, there is increasing demand for products that provide health benefits. According to the National Institute of Health, in a comprehensive multinational study using internet surveys, it was found that over 40% of the global population experiences gastrointestinal issues. The prevalence rates of diarrhea, constipation, or irritable bowel syndrome (IBS), were reported to be 4.7%, 11.7%, and 4.1%, respectively.

Consumers are becoming more proactive in seeking products that support digestive health, driven by a desire to prevent health issues and enhance their quality of life. Probiotic supplements, which contain beneficial bacteria known to support gut flora balance and digestive function, are gaining popularity as a convenient and effective way to achieve these health goals, driving market growth.

Increasing Consumer Probiotics Consumption

Consumers are becoming more aware of the health benefits associated with probiotics, such as improved digestive health and immune function. There is a growing focus on preventive healthcare and overall wellness, leading consumers to seek products that support gut health. Probiotics are perceived as natural and effective supplements that can promote a healthy digestive system.

In a 2021 survey conducted by the International Food Information Council, findings indicated that 51% of Americans incorporate probiotics into their diets to promote gut health, 33% use them to bolster immune function, 38% integrate probiotics for overall health and wellness purposes, and 13% reported consuming probiotics to support emotional well-being. The higher use of probiotic supplements is parallelly expanding market growth.

Lack of Consumer Awareness

Many consumers are unaware of the health consequences associated with poor gut health, such as increased risks of heart attack, stroke, and dementia. MDVIP survey shows 3 in 5 Americans don't know an unhealthy gut can increase heart attack, stroke and dementia risk. Two-thirds of Americans are living with gut issues, unaware of the health consequences.

This lack of awareness can lead to lower demand for gut health products, including probiotic supplements. Without a clear understanding of how probiotics can contribute to digestive health, immune function, and overall well-being, consumers may not perceive these supplements as essential or beneficial. This limits market growth potential.

Segment Analysis

The global gut health probiotic supplements market is segmented based on strain, form, distribution channel, age group, application and region.

Increasing Prevalence of Specific Health Conditions

The global gut health probiotic supplements market is segmented based on application into general digestive health, specific health conditions and others. The specific health conditions segment accounted for the largest share of the global market. Irritable bowel syndrome (IBS), inflammatory bowel disease (IBD) are some of the specific digestive health conditions that are commonly seen globally.

According to the International Foundation for Gastrointestinal Disorders, the worldwide estimation of IBS is reported to be 5-10% of the population. Similarly, in September 2023, results from a new study by Cedars-Sinai investigators revealed that irritable bowel syndrome is more prevalent than their previous estimation. The increasing prevalence of specific health conditions and the high prevalence of consumer willingness to take up natural curing measures drive segment growth.

Geographical Penetration

High Prevalence of Irritable Bowel Syndrome in North America

North America dominates the global gut health probiotic supplements market. North America, particularly United States and Canada, has a substantial population that is health-conscious and actively seeks preventive healthcare solutions. This strong cultural emphasis on health and wellness leads to a robust demand for products that support digestive health and overall well-being.

The high use of probiotic supplements in various aspects of application in North America is positively improving the market expansion in this region. According to the Food and Health Survey conducted by the International Food Information Council in April 2022, around 33% of respondents in United States try to include probiotics in their diets, with 60% aiming to do so daily.

North America's dominance in the global gut health probiotic supplements market is high due to the consumer interest in health and wellness and also advancements in product development. The region is a hub for research and innovation in healthcare and nutrition, fostering the development of advanced probiotic formulations and technologies along with the presence of leading global manufacturers.

Competitive Landscape

The major global players in the market include The Good Bug, Zeroharm Sciences Private Limited, Menoveda Life Sciences Private Limited, Unique Biotech Limited, Projoy Pvt Ltd, Nature's Bounty, Hyperbiotics, Advanced Vital Enzymes Private Ltd, Wren Laboratories Ltd and Nordic Naturals.

COVID-19 Impact Analysis

COVID-19 had a moderate impact on the global gut health probiotic supplements market. Initially, the market faced disruptions in raw material supply chains and manufacturing capabilities due to lockdowns and restrictions on movement. Some supplement manufacturers faced challenges in maintaining production levels and ensuring timely distribution due to logistical issues and workforce constraints.

The pandemic heightened awareness of the importance of immune health. Probiotics are known to support gut health, which in turn can influence immune function. This awareness may drive long-term demand for gut health supplements. With lockdowns and social distancing measures, there was a significant shift towards online shopping. This trend benefited e-commerce channels for supplement sales, allowing companies to reach consumers directly.

By Strain
• Lactobacillus
• Bifidobacterium
• Streptococcus
• Other

By Form
• Tablet
• Capsules
• Liquid
• Powder
• Others

By Distribution Channel
• Pharmacies/Drugstores
• Specialty Stores
• Online Retail
• Other

By Age-Group
• Children
• Adults
• Seniors

By Application
• General Digestive Health
• Specific Health Conditions
Irritable Bowel Syndrome (IBS)
Inflammatory Bowel Disease (IBD)
• Other

By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
UK
France
Italy
Russia
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa

Key Developments
• In August 2023, Hyperbiotics introduced PRO-IBS Support. This innovative product features a dual-action synergistic blend of Lactiplantibacillus plantarum 299v and highly bioavailable Boswellia serrata extract. The formulation aims to effectively alleviate gut discomfort and dysfunction in individuals with IBS.
• In August 2022, researchers at the University of Nottingham secured £1.8 million in funding for a three-year project to explore the potential benefits of cellulose-based food supplements for individuals suffering from Irritable Bowel Syndrome, focusing on colon fermentation.

Why Purchase the Report?
• To visualize the global gut health probiotic supplements market segmentation based on strain, form, distribution channel, age group, application and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of gut health probiotic supplements market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global gut health probiotic supplements market report would provide approximately 78 tables, 74 figures and 235 pages.

Target Audience 2024
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies


1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Strain
3.2. Snippet by Form
3.3. Snippet by Distribution Channel
3.4. Snippet by Age Group
3.5. Snippet by Application
3.6. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Growing Health Consciousness Among Consumers
4.1.1.2. Increasing Consumer Probiotics Consumption
4.1.2. Restraints
4.1.2.1. Lack of Consumer Awareness
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Strain
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
7.1.2. Market Attractiveness Index, By Strain
7.2. Lactobacillus
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Bifidobacterium
7.4. Streptococcus
7.5. Other
8. By Form
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
8.1.2. Market Attractiveness Index, By Form
8.2. Tablet
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Capsules
8.4. Liquid
8.5. Powder
8.6. Others
9. By Distribution Channel
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
9.1.2. Market Attractiveness Index, By Distribution Channel
9.2. Pharmacies/Drugstores
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Specialty Stores
9.4. Online Retail
9.5. Other
10. By Age Group
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
10.1.2. Market Attractiveness Index, By Age Group
10.2. Children
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Adults
10.4. Seniors
11. By Application
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.1.2. Market Attractiveness Index, By Application
11.2. General Digestive Health
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Specific Health Conditions
11.3.1. Irritable Bowel Syndrome (IBS)
11.3.2. Inflammatory Bowel Disease (IBD)
11.4. Other
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.8.1. U.S.
12.2.8.2. Canada
12.2.8.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.8.1. Germany
12.3.8.2. U.K.
12.3.8.3. France
12.3.8.4. Italy
12.3.8.5. Spain
12.3.8.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.8.1. Brazil
12.4.8.2. Argentina
12.4.8.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.8.1. China
12.5.8.2. India
12.5.8.3. Japan
12.5.8.4. Australia
12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Strain
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Age Group
12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis
14. Company Profiles
14.1. The Good Bug
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Zeroharm Sciences Private Limited
14.3. Menoveda Life Sciences Private Limited
14.4. Unique Biotech Limited
14.5. Projoy Pvt Ltd
14.6. Nature's Bounty
14.7. Hyperbiotics
14.8. Advanced Vital Enzymes Private Ltd
14.9. Wren Laboratories Ltd
14.10. Nordic Naturals
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings